Enlivex Therapeutics (ENLV) announced the enrollment and dosing of the first 10 patients in its Phase II Allocetra trial of individuals with ...
Israeli macrophage reprogramming immunotherapy company Enlivex Therapeutics (ENLV) announced “highly positive” clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback